Document is current
Any future updates will be listed below
-
Authors
Kelly, Patrick H.
Willis, Sarah
Davidson, Alexander
Stark, James H.
Moїsi, Jennifer C.
Estrada-Peña, Agustín
-
Funding
Funding for this research was provided by:
Pfizer & Valneva
- License Information
-
More Information
Article History
Received: 9 June 2025
Accepted: 6 September 2025
First Online: 14 October 2025
Declarations
:
: Not applicable.
: Not applicable.
: This analysis was supported and jointly funded by Valneva and Pfizer as part of their co-development of a Lyme disease vaccine. Patrick H. Kelly, Sarah Willis, Alexander Davidson, James H. Stark, and Jennifer C. Moїsi are employees of Pfizer and may hold shares and/or stock options in the company. Agustín Estrada-Peña is a paid consultant for Pfizer in connection with the development of this manuscript.
